OmniComm Signs Agreement with CROMSOURCE
Fort Lauderdale, FL, April 26, 2016 - OmniComm Systems, a global leading provider of clinical data management technology, today announced the signing of a five-year, multi-million dollar agreement with CROMSOURCE, a leading contract research organization (CRO), headquartered in Verona, Italy, with offices throughout Europe and North America. OmniComm’s
- TrialMaster
Custom Data Export Utility to create CDISC SDTM submission ready data
- Ad hoc reporting to create and share dashboards, reports, and analysis
Risk-based monitoring to centrally monitor key risk indicators (KRIs) and identify emerging risks
- across sites and subjects
- Support for adverse events, especially the ability to generate E2B exports with TrialMaster
SafetyLink , a requirement being requested more frequently by CROMSOURCE clients.
“It is an honor to be chosen by a CRO that is so well known for delivering quality and meeting stringent timelines,” said Stephen Johnson, president & COO of OmniComm. “TrialMaster’s intuitive usability coupled with extensive time-saving features is designed to reduce the time for set-up and promote efficiencies throughout the data collection process. We look forward to working with CROMSOURCE and their clients over the next five years!”
About CROMSOURCE
CROMSOURCE is an ISO-certified, international contract research organization providing a comprehensive portfolio of services to the pharmaceutical, biotechnology, and medical device industries. Specializing in clinical development and staffing solutions they offer a flexible approach to ensure their clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an end-to- end guarantee covering trial timelines, enrollment, and contract price. This guarantees our clients that their trials are delivered on-time and within the contract price with no CRO initiated change orders. CROMSOURCE operates offices across all regions of Europe and North America. For more information, visit
http://www.cromsource.com
.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,000 clinical trials. For more information, visit
www.omnicomm.com
.
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025